Back
Johnson & Johnson Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
29
JNJ
Johnson & Johnson
Last Price:
151.06
Seasonality Move:
2.59%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
67.05
Seasonality Move:
-6.93%
Sell
29
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $151.27. The Score for JNJ is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $151.27
The current trend is relatively stagnant and JNJ is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $65.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
JNJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 51.31 | Buy |
Chaikin Money Flow: | -7402100 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (146.33 - 151.77) | Buy |
Bollinger Bands (100): | (150.71 - 160.85) | Sell |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.32 | Sell |
Relative Strength Index (14 RSI): | 41.48 | Sell |
Chaikin Money Flow: | 421582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.45 - 74.29) | Sell |
Bollinger Bands (100): | (65.99 - 72.19) | Sell |
JNJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 151.9 | Sell |
20-day SMA: | 149.72 | Buy |
50-day SMA: | 152.16 | Sell |
200-day SMA: | 156.83 | Sell |
8-day EMA: | 151.94 | Sell |
20-day EMA: | 150.79 | Buy |
50-day EMA: | 151.97 | Sell |
200-day EMA: | 156.36 | Sell |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.78 | Sell |
20-day SMA: | 69.19 | Sell |
50-day SMA: | 68.67 | Sell |
200-day SMA: | 62.8 | Buy |
8-day EMA: | 66.34 | Sell |
20-day EMA: | 68 | Sell |
50-day EMA: | 68.71 | Sell |
200-day EMA: | 64.66 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.13 per share, an increase this year of $0.74 per share, and an increase next year of $0.31 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
Johnson & Johnson Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |